Diary - News
All news EVEON sign a new industrial partnership
EVEON, designer and manufacturer of medical devices for the preparation and/or administration of medicines, announces the signing of a new partnership in the framework of the CARAT (Consortium for Applications in Alpha Radiotherapy) project, aimed at developing a French network of excellence in nuclear medicine.
Within CARAT, EVEON, in collaboration with AREVA Med, will design, develop and manufacture a secure, innovative automated system for the production of lead-212 for treatment by radio-immunotherapy of certain particularly aggressive cancers against which the current armamentarium is limited.
By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree